SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
超人会飞233
Lv1
40 积分
2021-10-11 加入
最近求助
最近应助
互助留言
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study
1天前
已完结
[Chinese protocol of diagnosis and treatment of colorectal cancer of the National Health Commission (2023 edition)]
1个月前
已完结
Divarasib Plus Cetuximab Is Safe and Has Efficacy in Colorectal Cancer
1个月前
已关闭
Impact of Concurrent Genomic Alterations on Clinical Outcomes in Patients With ALK-Rearranged NSCLC
1个月前
已完结
Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization
1个月前
已完结
Divarasib Plus Cetuximab Is Safe and Has Efficacy in Colorectal Cancer
1个月前
已关闭
Precision Medicine in Pediatric Bithalamic Glioma: Significance of the EGFR exon 20 Insertion Mutation
2个月前
已完结
Droplet digital PCR improved the EGFR mutation diagnosis with pleural fluid samples in non-small-cell lung cancer patients
2个月前
已完结
Anti–Epstein–Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer
2个月前
已完结
CHEK2 deficiency increase the response to PD-1 inhibitors by affecting the tumor immune microenvironment
2个月前
已完结
Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 tria
9个月前
已驳回
不需要了【积分已退回】
1个月前
速度真快
1个月前
不需要了【积分已退回】
1个月前
感谢
5个月前
速度真快
6个月前
感谢,点赞
7个月前
感谢,点赞
7个月前
感谢,点赞,速度真快
8个月前
标题错误
9个月前
感谢,速度真快
10个月前
最近帖子
最近评论
搜索技巧
2023年AACR年会摘要集搜索技巧
1年前
没有发布任何评论